Kubera Venture Capital | LinkedIn (original) (raw)

Venture Capital and Private Equity Principals

Denver, Colorado 581 followers

Early stage investors (Pre-Seed to Series A) focused on Industry 4.0, Applied AI/ML, deep tech, B-B, and SaaS.

Discover all 5 employees

About us

We back companies and founders building the future and reimagining how we work and live by applying AI/ML. We invest in science, technology, and emerging business models powering the Future of Work, the Digital Workforce, Supply Chain, and Industry 4.0. We Invest Early Kubera is an early stage venture investment firm. Our "sweet spot" is in the Seed-Seed+ rounds; but we make exceptions for startups that could have great impact in our focus areas and often invest at Pre-Seed and early Series A. We Invest in Future of Work, the Digital Workforce, Intelligent Supply Chain, and Industry 4.0 Kubera's investments focus on technologies redefining the way businesses work to organize, operate, and compete to build new economies and ecosystems. The startups and founders we invest in are helping to digitize businesses across all industries. We Invest in Emerging Technologies The startups that we love are building defensible platforms and models using artificial intelligence, machine learning, data science, blockchain and 5G technologies. We love investing in data and believe AI/ML will be part of most platforms and solutions in the future. We also look at the infrastructure that powers and enables this reality. We Invest Across North America We believe that talent and opportunity is distributed and invest across North America. We are active in growing startup communities and embrace the diversity of culture, geography, ethnicity, and gender to bring unique ideas and perspectives to shape the future.

Industry

Venture Capital and Private Equity Principals

Company size

2-10 employees

Headquarters

Denver, Colorado

Type

Partnership

Founded

2019

Specialties

venture capital, future of work, industry 4.0, artificial intelligence, machine learning, blockchain, 5G, seed investment, pre-seed investment, Series A, enterprise software, SaaS, software as a service, and supply chain

Locations

Employees at Kubera Venture Capital

Updates

Well said partner.
🚨 Indee Labs posted a manuscript that applies TIMING™ from CellChorus to show that CAR-T cells manufactured with the Indee platform have superior motility and resistance to activation-induced cell death (AICD). 📖 Background: Indee is developing Hydropore, a non-viral technology that utilizes microfluidic vortex shedding to deliver small molecules, nucleic acids, proteins, and gene-editing complexes to immune cells with low impact to cell viability and function. The technology is designed to bypass the challenges and limitations of viral transduction and traditional transfection via electroporation, allowing scientists to accelerate their research goals from discovery to manufacturing. 📋 The approach: The team compared hydroporation with nucleofection in the generation of CAR-T cells. 📈 Key findings from the research include: - Scaled-up hydroporation can process 5 x 10^8 cells in less than 10 seconds. - Hydroporation yields a higher number of transfected cells compared to both nucleofection and electroporation, partly because CAR-T made with hydroporation (Hy-CAR-T) robustly grew and divided. - Hy-CAR-T cells CAR-T from nucleofection (Nuc-CAR-T) in terms of T cell subsets, activation, and pro-inflammatory cytokine secretion. - Hy-CAR-T secreted higher levels of the anti-inflammatory cytokine IL-10, which is linked to better CAR-T function. - TIMING data showed that individual Hy-CAR-T target seeking. contact dynamics, and target killing were just as robust as Nuc-CAR-T. - TIMING measurements of cell movements during target engagement (synapse) showed that Hy-CAR-Ts maintained significantly more motility than donor-matched Nuc-CAR-T cells. Motility has been linked to strong CAR-T potency and patient response in other studies. - TIMING data showed that Hy-CAR-T were resistant to activation-induced cell death (AICD) compared with Nuc-CAR-T. AICD contributes to exhaustion of engineered CAR-T cells 📜 Read more:https://lnkd.in/g2S7JF85Authors: Brandon Sytsma, Vincent Allain, Struan Bourke, Fairuz Faizee, Mohsen Fathi, Rebecca Berdeaux, Leonardo Ferreira, Jared Brewer, Lian Li, Fong Pan, Allison Rothrock, William Nyberg, Zongmei Lei, Leah Wilson, Justin Eyquem, ryan pawell Affiliations: University of California, San Francisco, Université Paris Cité médecine, Medical University of South Carolina, MUSC Hollings Cancer Center, Duke University School of Medicine, Institute for Human Genetics at UCSF, Parker Institute for Cancer Immunotherapy, Indee Labs, CellChorus #singleCell #CarT #cellTherapy #immunooncology #immunotherapy #ai #ml Y Combinator, BioTools Innovator
Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cells biorxiv.org
Generative AI has sparked considerable excitement over the last year or so, and we are grateful to have been part of these advancements in AI from the start. While AI has the power to be transformative, it's accompanied by significant risks and apprehensions as well. Enterprises grapple with the formidable task of operationalizing any use-case with Generative AI, encountering hurdles like unreliable outputs, vulnerabilities such as prompt injections and data privacy concerns. Our observations with AI in enterprise deployments highlighted these challenges, which have only magnified with Large Language Models (LLMs). When we met Sahil Agarwal and Prashanth Harshangi, we knew that they were incredibly bright, good humans, and thinking about this challenge in the right way to tackle this pressing issue. We are excited to be an investor in them and Enkrypt AI along with our co-investors below in building the future of AI to facilitate dependable and compliant adoption.#ai #aisecurity #aisafety #aistartups #venturecapital #venturefunding #enterpriseai James McKee Sena Zorlu Greg White Mark Janzen Paul J. Noble Katie Trauth Taylor, PhD Luke Moretti Yashar Behzadi Amanda Ducach VJ Sharma Kara Uchtman, P.E. Catherine O'Shea

Co-Founder & CEO @ Enkrypt AI | Math PhD, Yale
8mo
Building Enkrypt AI with Prashanth over the last year and half has been one of the most exciting and fulfilling experiences of my life. Today, I am delighted to announce our $2.35 million in funding to further our mission of safe, reliable and compliant adoption of Generative AI. There is a lot of buzz around generative AI, but so are the risks and concerns. The fact is, enterprises are struggling hard to operationalize any use-case with Generative AI due to unreliable outputs, vulnerabilities such as prompt-injections and issues with data privacy. We saw this problem firsthand with “regular AI” when deployed with enterprises, and it just grew exponentially with LLMs. We are building the most comprehensive solution to solve for this challenge, merging LLM visibility, data privacy and LLM vulnerabilities, ultimately leading to reliable and compliant adoption. More details on our research and exciting products updates to come soon. Thank you David Prosser for featuring our story in Forbes, highlighting the critical challenges and opportunities surrounding Gen AI. I would like to express my heartfelt gratitude to the team, Prashanth, Tanay, Divyanshu, Jatan and everyone who have been working passionately and tirelessly towards our mission. And we are super excited to partner with amazing investors, Sathya at BoldCap Chon, Brian, Riddhi, Capucine, Caroline at Berkeley SkyDeck, Balaji, James McKee at Kubera Venture Capital, Aarushi K. Yashwanth Hemaraj at Arka Venture Labs, Vinicius Pecora and Vaibhav Viswanathan and Shashank, Arpeet, 😎 Nishil, Adeesh at Builders Fund, Sanjeev, Sekhar, Pradipta and Vinod, Praveen, Laika, Javier to bring our vision to market. Together, we can ensure that Gen AI is a force for good, driving innovation and progress while mitigating potential risks.#llms #enterprise #security #reliability #privacy #compliance
Enkrypt AI Raises $2.35 Million To Take On The Chatbots Going Rogue forbes.com
Humbled to be part of the Narratize journey (along with our co-investors below) in developing novel approaches to generative AI and apply it across enterprises and their customers! Excited to back more female founders Katie Trauth Taylor, PhD Catherine O'Shea Kara Uchtman, P.E. and the power of applied AI.#genai #ai #femalefounders #venturecapital #venturefunding #llm James McKee Sena Zorlu Greg White Mark Janzen Kubera Venture Capital

CEO + Co-Founder Narratize AI | Inspiring Bold Ideas to Be Told | Generative Artificial Intelligence | New Product Development | R&D | Startup Exec Building Ambitious Products and Cultures
11mo Edited
As generative artificial intelligence becomes a top-down strategic imperative across enterprises globally, I am humbled and thrilled to share the news that:Narratize Closes $2M to Scale its Generative AI Coauthor for Innovative Enterprises Narratize combines the power of narrative science with cutting-edge generative AI technology to ensure that no great idea is left untold. From optimizing research & development processes to scaling product launch, Narratize empowers enterprises with transformative ideas to unleash their full potential. Our round was led by Kubera Venture Capital and HearstLab, with participation from Cintrifuse Capital, Keyhorse Capital, North Coast Ventures, How Women Invest, and Fireroad. The funding will be used to accelerate the development of Narratize's AI platform, which helps enterprises in scientific, technical, and medical industries generate accurate, compelling content and communications to speed time to market for innovative products and initiatives. To my incredible cofounders, Catherine O'Shea and Kara Uchtman, P.E. and the groundbreaking team who got us here: WOW! Stephen Taylor, Alicia Surrao, PhD, Kate Greulich, Ph.D., Kendall Leon, Ph.D., Brian Kraack, Rachel Keeney--It is my professional joy to work alongside you to accomplish technical feats for our customers. To our champions! Sue Bevan Baggott, Santhosh Devati, Balaji Gopinath, James McKee, Alicia Hong, Toby Eduardo Redshaw, Eve Burton, Dave Knox, Corey Myers, Main Street Ventures, Julie Castro Abrams, Glen Coppersmith, Abran Maldonado, Pete Blackshaw, Jeremy Wheaton, Max Dworin, Nate Sowder, Daniel Luketic, Kelby Price, Seth Hollander, MD, John Stieger, Jose J. Pacheco, Letty Garcia, Robert Clauser, Kushala Silva. You are so integral to our existence--from our big reason "why" to the roadmap we build together to transform the world for good.#ai #genai #chatgpt #gpt #llm #generativeai #researchanddevelopment #innovation #storytelling #innovationmanagement #startupnews #femalefounded
Narratize Closes $2M Seed Round to Accelerate Innovation Through the Power of Story bigtechnology.com

Join now to see what you are missing

Join now

Kubera Venture Capital | LinkedIn (original) (raw)

Venture Capital and Private Equity Principals

Denver, Colorado 581 followers

Early stage investors (Pre-Seed to Series A) focused on Industry 4.0, Applied AI/ML, deep tech, B-B, and SaaS.

About us

Locations

Employees at Kubera Venture Capital

Updates

Join now to see what you are missing

Similar pages

Browse jobs